Viewing Study NCT02575560


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-01 @ 5:37 PM
Study NCT ID: NCT02575560
Status: COMPLETED
Last Update Posted: 2018-02-14
First Post: 2015-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)
Sponsor: Qingdao Central Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-01
Start Date Type: None
Primary Completion Date: 2017-09-30
Primary Completion Date Type: ACTUAL
Completion Date: 2017-12-31
Completion Date Type: ACTUAL
First Submit Date: 2015-10-08
First Submit QC Date: None
Study First Post Date: 2015-10-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-02-13
Last Update Post Date: 2018-02-14
Last Update Post Date Type: ACTUAL